SCHEMBL6023945

SCHEMBL6023945

CCCc1[c]cc(CCC)c(OC)c1OC

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6023394 0.76 HMGCR (0.34) HMGCR
SCHEMBL3551837 0.75 HMGCR (0.39) HMGCR
SCHEMBL6024098 0.74 HMGCR (0.33) HMGCR
SCHEMBL9346100 0.72 ALOX5 (0.35)
SCHEMBL7842427 0.70 TYR (0.33)
SCHEMBL814614 0.69
SCHEMBL3544366 0.69 HMGCR (0.43) HMGCR
SCHEMBL6023375 0.68
SCHEMBL8476328 0.67 PDE4B (0.40)
SCHEMBL8475248 0.66 MGAM (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880523-B1 PYRAZOLOPYRIMIDINES AS CRF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES INC (US) 2006-08-16 EP disclosed
EP-0880523-A1 PYRAZOLOPYRIMIDINES AS CRF RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1998-12-02 EP disclosed
WO-1997029109-A1 PYRAZOLOPYRIMIDINES AS CRF RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1997-08-14 WO disclosed